Movement disorder society criteria for clinically established early Parkinson's disease
Daniela Berg(Christian-Albrechts-Universität zu Kiel), Ronald B. Postuma(Montreal Neurological Institute and Hospital), Christopher G. Goetz(Rush University Medical Center), Ian O. Bledsoe(University of California, San Francisco), Charles H. Adler(WinnMed), Bastiaan R. Bloem(Radboud University Nijmegen), Silvia Ríos‐Romenets(Montreal General Hospital), Glenda M. Halliday(UNSW Sydney), Piu Chan(Capital Medical University), Corina Maetzler(Christian-Albrechts-Universität zu Kiel), Werner Poewe(University of Verona), Beatrice Heim(Innsbruck Medical University), Wolfgang H. Oertel(Philipps University of Marburg), José Á. Obeso(Biomedical Research Networking Center on Neurodegenerative Diseases), Elizabeth Slow(Toronto Western Hospital), Thomas Gasser(Hertie Institute for Clinical Brain Research), Matthew Stern(Penn Center for AIDS Research), Günther Deuschl(Christian-Albrechts-Universität zu Kiel), Inga Liepelt‐Scarfone(German Center for Neurodegenerative Diseases), Taomian Mi(Capital Medical University), Simon J.G. Lewis(School of the Art Institute of Chicago), Klaus Seppi(Innsbruck Medical University), C. Warren Olanow(Icahn School of Medicine at Mount Sinai), Kenneth Marek(University of Pennsylvania), Yuan Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Anthony E. Lang(Unknown), Eva Schäffer, Irene Litvan(Johns Hopkins University)
Cited by 172
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k